Cargando…

Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer

BACKGROUND: The prognostic nutritional index (PNI), which is an easily calculated nutritional index, is significantly associated with patient outcomes in various solid malignancies. This study aimed to evaluate the prognostic impact of PNI changes in patients with breast cancer undergoing neoadjuvan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oba, Takaaki, Maeno, Kazuma, Takekoshi, Daiya, Ono, Mayu, Ito, Tokiko, Kanai, Toshiharu, Ito, Ken-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045374/ https://www.ncbi.nlm.nih.gov/pubmed/32106833 http://dx.doi.org/10.1186/s12885-020-6647-4

Ejemplares similares

Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer
por: Amitani, Masatsugu, et al.
Publicado: (2022)

Papillary thyroid microcarcinoma with lung metastases: a case report and review of the literature
por: Shimizu, Tadafumi, et al.
Publicado: (2021)

Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review
por: Oba, Takaaki, et al.
Publicado: (2016)

Fibroadenoma in a young male breast: A case report and review of the literature
por: Morikawa, Hiroki, et al.
Publicado: (2021)

Development of a predictive score for post-hemithyroidectomy hypothyroidism using skeletal muscle index, remnant thyroid index, and thyroid-stimulating hormone levels: a retrospective cohort study
por: Amitani, Masatsugu, et al.
Publicado: (2023)

Breast metastases of gastric signet-ring cell carcinoma: a report of two cases and review of the literature
por: Iesato, Asumi, et al.
Publicado: (2014)

Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer
por: Ono, Mayu, et al.
Publicado: (2013)

Human 3β‐hydroxysteroid dehydrogenase type 1 in human breast cancer: clinical significance and prognostic associations
por: Hanamura, Toru, et al.
Publicado: (2016)

The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time
por: Ono, Mayu, et al.
Publicado: (2021)

Hypercalcemic crisis caused by primary hyperparathyroidism in a 11-year-old boy: a rare case report and review of the literature
por: Hayashi, Shigeki, et al.
Publicado: (2022)

Combination of two anti-tubulin agents, eribulin and paclitaxel, enhances anti-tumor effects on triple-negative breast cancer through mesenchymal-epithelial transition
por: Oba, Takaaki, et al.
Publicado: (2018)

ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines
por: Oba, Takaaki, et al.
Publicado: (2016)

The Advantage of Using an Optical See-Through Head-Mounted Display in Ultrasonography-Guided Needle Biopsy Procedures: A Prospective Randomized Study
por: Shimizu, Tadafumi, et al.
Publicado: (2023)

FGF2-FGFR1 pathway activation together with thymidylate synthase upregulation is induced in pemetrexed-resistant lung cancer cells
por: Miura, Kentaro, et al.
Publicado: (2019)

Predictive value of immuno-inflammatory and nutritional measures modulated by neoadjuvant chemotherapy on the response of neoadjuvant chemotherapy and long-term outcomes in patients with esophageal cancer
por: Ishibashi, Yusuke, et al.
Publicado: (2020)

Radical Resection for Locally Advanced Pancreatic Cancers in the Era of New Neoadjuvant Therapy—Arterial Resection, Arterial Divestment and Total Pancreatectomy
por: Inoue, Yosuke, et al.
Publicado: (2021)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Wong, Willard, et al.
Publicado: (2021)

Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer
por: Watanabe, Takayuki, et al.
Publicado: (2021)

Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy
por: Ma, Youzhao, et al.
Publicado: (2023)

Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Ma, Youzhao, et al.
Publicado: (2021)

Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy
por: Hu, Taobo, et al.
Publicado: (2022)

Pathologic method for extracting good prognosis group in triple‐negative breast cancer after neoadjuvant chemotherapy
por: Eguchi, Yuki, et al.
Publicado: (2022)

Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer
por: Li, Kai, et al.
Publicado: (2016)

Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis
por: Tamiya, Hironari, et al.
Publicado: (2018)

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Liu, Zining, et al.
Publicado: (2021)

Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
por: Zhou, Xu, et al.
Publicado: (2023)

A Case of Severe and Recurrent Painless Thyroiditis Requiring Thyroidectomy
por: Ishii, Hiroaki, et al.
Publicado: (2013)

A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

Decreased handgrip strength can predict lung function impairment in male workers: a cross sectional study
por: Kanai, Makiko, et al.
Publicado: (2020)

Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
por: Wu, Yanan, et al.
Publicado: (2017)

Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
por: Ichida, Hirofumi, et al.
Publicado: (2019)

IS THERE ANY DIFFERENCE IN THE PROGNOSIS FOR PATIENTS WITH PRIMARY OSTEOSARCOMA WITH A POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY BETWEEN HUVOS GRADES I AND II?
por: Bispo Júnior, Rosalvo Zósimo, et al.
Publicado: (2015)

Congenital anterior staphyloma associated with Peters’ anomaly and aphakia in a Holstein calf
por: SATO, Reiichiro, et al.
Publicado: (2017)

Nutritional Status Impairment Due to Neoadjuvant Chemotherapy Predicts Post-Radical Cystectomy Complications
por: Cohen, Sharon, et al.
Publicado: (2021)

Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2022)

Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
por: Rutten, Iris J.G., et al.
Publicado: (2016)

Decrease of peripheral blood lymphocyte count predicts response to neoadjuvant chemotherapy in breast cancer patients
por: Lee, Ok Hee, et al.
Publicado: (2020)

Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis
por: FUJITA, NORIKO, et al.
Publicado: (2014)

Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
por: Nakamura, Kazuto, et al.
Publicado: (2020)

Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy
por: Zarotti, Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hic0771n9r7d40667kvgeng1sh